Identification and Characterization of Multiple HLA-A24-Restricted HIV-1 CTL Epitopes: Strong Epitopes are Derived from V Regions of HIV-1

Journal of Immunology

Volumn 159, Issue 12, 1997, Pages 6242-6252

  Ikeda Moore, Yuki ^a   Tomiyama, Hiroko ^a,b   Miwa, Kiyoshi ^d   Oka, Shinichi ^c   Iwamoto, Aikichi ^a   Kaneko, Yutaro ^d   Takiguchi, Masafumi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120; HLA A ANTIGEN; HLA A24 ANTIGEN; PEPTIDE;

ALLELE; ARTICLE; CELL CLONE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; METABOLISM; MUTATION; PROTEIN BINDING;

ALLELES; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HLA-A ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MUTATION; PEPTIDES; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031573617     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type I syndrome. J. Virol. 68:4650.
2. + T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 370:463.
3. Langlade-Demoyen, P., N. Ngo-Giang-Huong, F. Ferchal, and E. Oksenhendler. 1994. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J. Clin. Invest. 93:1293.
4. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1:59.
5. Klein, M. R., C. A. van Baalen, A. M. Holwerda, S. R. K. Garde, R. J. Bende, I. P. M. Keet, J. K. M. Eeftinck-Schattenkerk, A. D. M. E. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med 181:1365.
6. Nowak, M. A., R. M. Anderson, A. R. McLean, T. F. W. Wolfs, J. Goudsmit, and R. M. May. 1991. Antigenic diversity thresholds and the development of AIDS. Science 254:963.
7. Wolinsky, S. M., B. T. M. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537.
8. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Köppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403.
9. Meier, U. C., P. Klenerman, P. Griffin, W. James, B. Köppe, B. Larder, A. McMichael, and R. Phillips. 1995. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science 270:1360.
10. b cytotoxic T lymphocytes. J. Exp. Med. 168:559.
11. + cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein. Proc. Natl. Acad. Sci. USA 88:10277.
12. Johnson, R. P., A. Trocha, T. M. Buchanan, and B. D. Walker. 1992. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175:961.
13. Johnson, R. P., A. Trocha, T. M. Buchanan, and B. D. Walker. 1993. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone. J. Virol. 67:438.
14. + A24-restricted cytotoxic T lymphocytes. J. Virol. 66:3151.
15. Koenig, S., R. M. Woods, Y. A. Brewah, A. J. Newell, G. M. Jones, E. Boone, J. W. Adelsberger, M. W. Baseler, S. M. Robinson, and S. Jacobson. 1993. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neuralgic disease. J. Immunol. 156:3874.
16. Shiga, H., T. Shioda, H. Tomiyama, Y. Takamiya, S. Oka, S. Kimura, Y. Yamaguchi, T. Gojoubori, H. G. Rammensee, K. Miwa, and M. Takiguchi. 1996. Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules. AIDS 10:1075.
17. Hill, A. V. S., J. Elvin, A. C. Willis, M. Aidoo, C. E. M. Allsopp, F. M. Gotch, X. M. Gao, M. Takiguchi, B. M. Greenwood, A. R. M. Townsend, A. J. McMichael, and H. C. Whittle. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434.
18. Park, M. H., T. Juji, and K. Tokunaga. 1992. HLA ethnic study of Japanese and Koreans. In HLA 1991, Vol. 1. K. Tsuji, M. Aizawa, and T. Sasazuki, eds. Oxford University Press, Oxford, U.K., p. 674.
19. Imanishi, T., T. Akaza, A. Kimura, K. Tokunaga, and T. Gojobori. 1992. Allele and haplotype frequencies for HLA and complement loci in various ethnic group. In HLA 1991, Vol. 1. K. Tsuji, M. Aizawa, and T. Sasazuki, eds. Oxford University Press, Oxford, U.K., p. 1065.
20. Karaki, S., A. Kariyone, N. Kato, Y. Iwakura, and M. Takiguchi. 1993. HLA-B51 transgenic mice as recipients for production of polymorphic anti-HLA-A, B antibodies. Immunogenetics 37:139.
21. Ibe, M., Y. Ikeda Moore, K. Miwa, Y. Kaneko, S. Yokota, and M. Takiguchi. 1996. Role of strong anchor residues in the effective binding of 10-mer and 11-mer peptides to HLA-A*2402 molecules. Immunogenetics 44:233.
22. Matsumoto, K., J. Yamamoto, M. Hiraiwa, K. Kano, and M. Takiguchi. 1990. Discrimination of HLA-B5 cross reactive group antigen by human allospecific CTL clones. Transplantation 49:1164.
23. Maier, R., K. Falk, O. Rötzschke, B. Maier, V. Gnau, S. Stevanovic, G. Jung, H.-G. Rammensee, and A. Meyerhans. 1994. Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing. Immunogenetics 40:306.
24. Falk, K., O. Rötzschke, B. Grahovac, D. Schendel, S. Stevanovic, V. Gnau, G. Jung, J. L. Strominger, and H. G. Rammensee. 1993. Allele-specific peptide ligand motifs of HLA-C molecules. Proc. Natl. Acad. Sci. USA 90:12005.
25. Tomiyama, H., K. Miwa, H. Shiga, Y. Ikeda-Moore, S. Oka, A. Iwamoto, Y. Kaneko, and M. Takiguchi. 1997. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS. J. Immmunol. 158:5026.
26. Harrer, E., T. Harrer, P. Barbosa, M. Feinberg, R. P. Johnson, S. Buchbinder, and B. D. Walker. 1996. Recognition of the highly conserved YMDD region on the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J. Infect. Dis. 173:476.
27. Walker, B. D., C. Flexner, K. Birch-Limberger, L. Fisher, T. J. Paradis, A. Aldovini, R. Young, B. Moss, and R. T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:9514.
28. Dupuis, M., S. K. Kundu, and T. C. Merigan. 1995. Characterization of HLA-A*0201-restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 protein. J. Immunol. 155:2232.
29. Johnson, R. P., A. Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M. Buchanan, and B. D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. J. Immunol. 147:1512.
30. Nixon, D. F., and A. J. McMichael. 1991. Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS 5:1049.
31. Dadaglio, G., A. Leroux, P. Langlade-Demoyen, E. M. Bahraoui, F. Traincard. R. Fisher, and F. Plata. 1991. Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes. J. Immunol. 147:2302.
32. + T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc. Natl. Acad. Sci. USA 88:11276.
33. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180: 1283.
34. Gagliardi, M. C., G. D. Petrillo, S. Salemi, L. Boffa, M. G. Longobardi. P. Dellabona, G. Casorati, N. Tanigaki, R. Harris, A. Lanzavecchia, and V. Barnaba. 1995. Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Int. Immunol. 7:1741.
35. van der Burg, S. H., M. R. Klein, C. H. J. van de Velde, W. M. Kast, F. Miedema, and C. J. M. Melief. 1995. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-reverse transcriptase. AIDS 9:121.
36. Brander, C., W. J. Pichler, and G. Corradin. 1995. Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine. Clin. Exp. Immunol. 101:107.
37. Hadida, F., G. Haas, N. Zimmermann, A. Hosmalin, R. Spohn, A. Samri, G. Jung, P. Debre, and B. Autran. 1995. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 nef. J. Immunol. 154:4174.
38. Kaslow, R. A., M. Carrington, R. Apple, L. Park, A. Muñoz, A. J. Saah, J. J. Goedert, C. Winkler, S. J. O'Brien, C. Rinaldo, R. Detels, W. Blattner, J. Phair, H. Erlich, and D. L. Mann. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med. 2:405.